CA Patent

CA3236835A1 — C/ebp alpha short activating rna compositions and methods of use

Assigned to Mina Therapeutics Ltd · Expires 2015-05-28 · 11y expired

What this patent protects

The invention relates to saRNA targeting a C/EBPa transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.

USPTO Abstract

The invention relates to saRNA targeting a C/EBPa transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
CA3236835A1
Jurisdiction
CA
Classification
—
Expires
2015-05-28
Drug substance claim
No
Drug product claim
No
Assignee
Mina Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.